Maximus, Inc. $MMS Stake Boosted by Walleye Capital LLC

Key Points

• Walleye Capital LLC increased its holdings in Maximus, Inc. by 162.3% in Q1, owning 134,743 shares valued at approximately $9.2 million.
• Additionally, a number of hedge funds have also increased their positions, with 97.21% of Maximus's stock now owned by institutional investors.
• Maximus declared a quarterly dividend of $0.30 per share, reflecting an annualized yield of 1.4%, to be paid to shareholders on August 31.

Walleye Capital LLC increased its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 162.3% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 134,743 shares of the health services provider's stock after purchasing an additional 83,373 shares during the quarter. Walleye Capital LLC owned 0.24% of Maximus worth $9,188,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. LRI Investments LLC increased its position in Maximus by 11.9% during the 1st quarter. LRI Investments LLC now owns 1,833 shares of the health services provider's stock worth $125,000 after purchasing an additional 195 shares in the last quarter. Vestcor Inc increased its position in Maximus by 2.3% during the 1st quarter. Vestcor Inc now owns 9,877 shares of the health services provider's stock worth $674,000 after purchasing an additional 223 shares in the last quarter. Cetera Investment Advisers increased its position in Maximus by 5.8% during the 1st quarter. Cetera Investment Advisers now owns 4,519 shares of the health services provider's stock worth $308,000 after purchasing an additional 247 shares in the last quarter. UMB Bank n.a. increased its position in Maximus by 70.2% during the 1st quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock worth $41,000 after purchasing an additional 250 shares in the last quarter. Finally, Nisa Investment Advisors LLC increased its position in Maximus by 0.7% during the 1st quarter. Nisa Investment Advisors LLC now owns 39,936 shares of the health services provider's stock worth $2,723,000 after purchasing an additional 290 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.

Insider Activity at Maximus

In other news, Director Gayathri Rajan sold 7,913 shares of the stock in a transaction that occurred on Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the completion of the transaction, the director directly owned 14,205 shares in the company, valued at approximately $1,028,157.90. This represents a 35.78% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 1.60% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on MMS. Zacks Research raised shares of Maximus from a "hold" rating to a "strong-buy" rating in a research report on Tuesday. Wall Street Zen cut Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Strong Buy" and an average target price of $90.00.

Maximus Stock Up 0.1%

Shares of Maximus stock traded up $0.10 on Thursday, hitting $87.66. 552,291 shares of the company's stock traded hands, compared to its average volume of 699,551. The stock has a market cap of $4.94 billion, a P/E ratio of 16.14 and a beta of 0.60. The company has a quick ratio of 2.27, a current ratio of 2.27 and a debt-to-equity ratio of 0.91. The firm's 50-day moving average is $75.92 and its 200 day moving average is $71.50. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.94.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, beating the consensus estimate of $1.39 by $0.77. The company had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.29 billion. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The business's revenue was up 2.5% on a year-over-year basis. During the same period in the prior year, the business posted $1.74 EPS. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Equities analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Sunday, August 31st. Stockholders of record on Friday, August 15th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. The ex-dividend date is Friday, August 15th. Maximus's dividend payout ratio is 22.10%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.